Commission signs joint procurement contract for up to 24 million doses of RSV vaccine ahead of the 2026-2027 winter season
The European Commission has signed a joint procurement framework contract with Moderna to access up to 24 million doses of the mRNA-based RSV (Respiratory Syncytial Virus) vaccine mRESVIA®.
Eight vaccines linked to a lower risk of dementia
A growing body of research is beginning to reveal the impact that regular routine vaccines could be having on the likelihood of conditions like dementia.
Manual for respiratory virus vaccination coverage: monitoring and reporting seasonal influenza, COVID-19, and respiratory syncytial virus immunization
This manual provides guidance for countries on monitoring and reporting vaccination coverage for seasonal influenza, COVID-19 and respiratory syncytial virus (RSV) immunization programmes.
Summary Report: IDC Stakeholder Community Meeting - 10 June 2026, Brussels
Key takeaways and next steps from the first in-person meeting of the IDC
ESWI Activity Report for 2025
Maternal RSV vaccination generates high-affinity antibodies that efficiently transfer to infants, providing enhanced passive immunity
These findings demonstrate that maternal RSV vaccination generates high-quality, affinity-matured transferable antibodies that provide passive immunity to infants.
News
Policy & Recommendations
Europe strengthens lab defences against key pathogens
ESWI Chair Colin Russell was featured in a Medscape article on the EU reference laboratories aiming to improve disease surveillance data, including respiratory viruses.
World Immunization Week 2026
Under the theme, “For every generation, vaccines work”, the World Immunization Week will promote how vaccines have safely protected people, families and communities for generations .
